Wave Life Sciences
Tracked across 3 events · 18 articles · First seen May 20, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on RNA medicines, announced on September 22, 2026 the appointment of Monika Vnuk, MD, as Chief Business Officer, a newly created leadership role. Dr.…
Impact: Wave Life Sciences is the central entity, appointing Monika Vnuk as Chief Business Officer to lead business development and corporate development. The move is intended to support pipeline advancement and future transactions, and its shares rose 2.44 percent on the news.
Sep 22, 2026 · 6 articles
Tech
Impact: Wave Life Sciences participated in a panel discussion, underscoring the importance of stereochemical control in RNAi manufacturing.
May 20, 2026 · 6 articles
Business
Impact: Previous employer of David Butler, mentioned as background. No direct impact.
Aug 03, 2026 · 6 articles
85
Wave Life Sciences appointed Monika VnukWave Life Sciences...
50
Wave Life Sciences granted stock options Monika VnukWave Life Sciences...
ERGEN INTELLIGENCE
Track Wave Life Sciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard